DNA2.0 Names Walter Tian Senior Vice President, Marketing And Corporate Strategy
Bioengineering solutions provider DNA2.0 in Menlo Park has announced that Walter Tian has joined the company as Senior Vice President for Marketing and Corporate Strategy in order to help the company meet growing customer demand. An MBA graduate of Northeastern University, Mr. Tian has more than 25 years of experience as a marketing executive in biotech and the life sciences industry. Mr. Tian spent nearly five years leading a global business team focused on siRNA and miRNA portfolio development at QIAGEN. Most recently, Mr. Tian was Vice President for Marketing at OriGene, where he was instrumental in helping transition the company's focus from gene products to complete gene research solutions.
DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 provides an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly ef"cient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Menlo Park, Calif. For more information, please visit www.DNA20.com